PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27999284-4	2016	We demonstrated that aspirin inhibited hepcidin mRNA as well as NO production in cells treated with LPS, but not in cells without LPS, suppresses IL-6, JAK2, STAT3, and P65 (nuclear factor-kappaB) phosphorylation and has no effect on IRP1 in cells treated with or without LPS.	Aspirin	21-28	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	169-172	
27999284-5	2016	These findings provide evidence that aspirin down regulates hepcidin by inhibiting IL6/JAK2/STAT3 and P65 (nuclear factor-kappaB) pathways in the cells under inflammatory conditions, and imply that an aspirin-induced reduction in TfR1 and an increase in ferritin are not associated with IRP1 and NO.	Aspirin	37-44	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	102-105	
27430169-6	2016	The immunofluorescence assay indicated that aspirin markedly inhibited NF-kappaB p65 translocation to the nucleus in RANKL-induced RAW264.7 cells.	Aspirin	44-51	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	81-84	
28119929-6	2016	Proinflammatory cytokines were decreased and the expression of NF-kappaB p65 in acinar cell nuclei was suppressed after aspirin treatment.	Aspirin	120-127	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	73-76	
19880966-11	2010	Using real-time PCR we found a significant downregulation of the target genes VEGF and RelA demonstrating our ability to achieve effective pharmacological levels of aspirin and enalapril during pancreatic cancer formation in vivo.	Aspirin	165-172	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	87-91